VERTEX PHARMACEUTICALS INC / MA Quarterly Entity Common Stock, Shares Outstanding from Q1 2010 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2010 to Q2 2024.
  • Vertex Pharmaceuticals Inc / Ma Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 258M shares, a 0% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 258M +7.39K +0% Jul 31, 2024 10-Q 2024-08-02
Q1 2024 258M +502K +0.2% Apr 30, 2024 10-Q 2024-05-07
Q4 2023 258M +1.22M +0.47% Feb 9, 2024 10-K 2024-02-15
Q3 2023 258M +992K +0.39% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 258M +1.64M +0.64% Jul 31, 2023 10-Q 2023-08-02
Q1 2023 258M +1.8M +0.7% Apr 25, 2023 10-Q 2023-05-02
Q4 2022 257M +2.51M +0.99% Jan 31, 2023 10-K 2023-02-10
Q3 2022 257M +2.44M +0.96% Oct 21, 2022 10-Q 2022-10-28
Q2 2022 256M -2.97M -1.14% Jul 29, 2022 10-Q 2022-08-05
Q1 2022 256M -3.11M -1.2% Apr 29, 2022 10-Q 2022-05-06
Q4 2021 255M -5.38M -2.07% Jan 31, 2022 10-K 2022-02-09
Q3 2021 254M -5.79M -2.23% Oct 29, 2021 10-Q 2021-11-03
Q2 2021 259M -1.04M -0.4% Jul 23, 2021 10-Q 2021-07-30
Q1 2021 259M -411K -0.16% Apr 22, 2021 10-Q 2021-04-30
Q4 2020 260M +691K +0.27% Jan 31, 2021 10-K 2021-02-11
Q3 2020 260M +2.89M +1.12% Oct 23, 2020 10-Q 2020-10-30
Q2 2020 260M +3.43M +1.34% Jul 23, 2020 10-Q 2020-07-31
Q1 2020 259M +3.16M +1.23% Apr 24, 2020 10-Q 2020-05-01
Q4 2019 259M +3.61M +1.41% Jan 31, 2020 10-K 2020-02-13
Q3 2019 257M +1.59M +0.62% Oct 18, 2019 10-Q 2019-10-31
Q2 2019 257M +1.48M +0.58% Jul 26, 2019 10-Q 2019-08-01
Q1 2019 256M +1.29M +0.51% Apr 24, 2019 10-Q 2019-05-01
Q4 2018 256M +1.76M +0.7% Jan 31, 2019 10-K 2019-02-13
Q3 2018 256M +2.66M +1.05% Oct 19, 2018 10-Q 2018-10-25
Q2 2018 256M +3.44M +1.37% Jul 20, 2018 10-Q 2018-07-26
Q1 2018 255M +5.76M +2.31% Apr 20, 2018 10-Q 2018-04-27
Q4 2017 254M +5.45M +2.2% Jan 31, 2018 10-K 2018-02-15
Q3 2017 253M +4.87M +1.96% Oct 20, 2017 10-Q 2017-10-30
Q2 2017 252M +4.34M +1.75% Jul 21, 2017 10-Q 2017-07-28
Q1 2017 249M +1.72M +0.7% Apr 21, 2017 10-Q 2017-04-28
Q4 2016 248M +2.05M +0.83% Feb 10, 2017 10-K 2017-02-23
Q3 2016 248M +2.32M +0.94% Oct 21, 2016 10-Q 2016-10-31
Q2 2016 248M +3.12M +1.28% Jul 22, 2016 10-Q 2016-08-01
Q1 2016 247M +3.6M +1.48% Apr 20, 2016 10-Q 2016-05-03
Q4 2015 246M +4.3M +1.78% Jan 31, 2016 10-K 2016-02-16
Q3 2015 246M +5.2M +2.16% Oct 23, 2015 10-Q 2015-10-30
Q2 2015 245M +6.57M +2.76% Jul 24, 2015 10-Q 2015-08-04
Q1 2015 244M +7.56M +3.2% Apr 24, 2015 10-Q 2015-05-04
Q4 2014 242M +6.32M +2.68% Jan 31, 2015 10-K 2015-02-13
Q3 2014 241M +6.76M +2.89% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 238M +5.27M +2.26% Jul 25, 2014 10-Q 2014-07-31
Q1 2014 236M +14.8M +6.68% Apr 25, 2014 10-Q 2014-05-05
Q4 2013 236M Feb 5, 2014 10-K 2014-02-11
Q3 2013 234M +16.9M +7.81% Oct 31, 2013 10-Q 2013-11-07
Q2 2013 233M +17M +7.88% Jul 26, 2013 10-Q 2013-08-02
Q1 2013 221M +10.3M +4.9% Apr 26, 2013 10-Q 2013-05-08
Q3 2012 217M +8.26M +3.96% Oct 26, 2012 10-Q 2012-11-06
Q2 2012 216M +7.72M +3.71% Jul 27, 2012 10-Q 2012-08-08
Q1 2012 211M +5.06M +2.46% Apr 27, 2012 10-Q 2012-05-10
Q4 2011 210M +5.92M +2.9% Feb 8, 2012 10-K 2012-02-22
Q3 2011 209M +5.37M +2.64% Oct 28, 2011 10-Q 2011-11-03
Q2 2011 208M +5.26M +2.59% Jul 29, 2011 10-Q 2011-08-09
Q1 2011 206M +3.79M +1.88% Apr 28, 2011 10-Q 2011-05-06
Q4 2010 204M Feb 9, 2011 10-K 2011-02-17
Q3 2010 203M Oct 21, 2010 10-Q 2010-10-28
Q2 2010 203M Jul 29, 2010 10-Q 2010-08-03
Q1 2010 202M Apr 22, 2010 10-Q 2010-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.